Factors associated with serum levels of estradiol and sex hormone-binding globulin among premenopausal Japanese women. by Nagata, C et al.
Factors Associated with Serum Levels of Estradiol and Sex Hormone-
binding Globulin among Premenopausal Japanese Women
Chisato Nagata,1 NobuyukiKaneda,2 MichinoriKabuto,2 andHiroyukiShimizu1
'Department of Public Health, Gifu University School of Medicine, Gifu, Japan; 2Urban Environment & Health Project, National Institute
for Environmental Studies, Ibaraki, Japan
We measured serum levels ofestadiol (E2) and sex mn e-binding globulin (SHBG) among
50 healthy premenopausal Japanese women in 1994 in Gif Japan, to iiwestigate the reltion-
ships between potential risk factor for brenst sncer and hormone levels. Using a self-adminis-
tered quio , wecol.le.ted daao boy ephical activit-andprevious diseas_histo-
ry, as well as et and hisories ofhewomanFandhe . Blood smples
were drawn eachsuject.on the lltJ and 22nddaiy ofher menstrl cyle H*gher serum
Zlevels woere obervee for women with shorter menrl ces. Age as wel as cycle length
were inlde the r ion modes to determine the aoations beten hormone letels
andstudyvariables. Body mass index (BMI) was invendry elated toSHBG levdmeasured at the
11thdayofthecycle, afteradjusting forage andcyclelength (r - -0.33;p - 9.03). Womenborn
in spring/summer hadhigherlevels ofE; on the 22ndday(p =0.07) andhigherlevelsofSHBG
onD oth the 11th and 22nd days ofthe cycle (p 0.01 andp 0.06, respectvy) than those
born in other assons. Physicd activity at 13-15 s ofage wa inversy rlat to E ll on
the 11thdayofthecycleaftercontrollingforage,cycle length, BMI, andbirth month (r -0.35;
pa= 0.04). Kgy5*70T body maxss index, stradiol,Ja e, monthofbirth, se hormone-binding
globulin, physical acivity, premenopause.
EnvironHeal Perset105:994-997 (1997). /Snplle/.iniehs.nih.gv
Endogenous hormones, particularly estro-
gens, have been implicated in the etiology
of breast cancer (1). Recently, numerous
studies have focused not only on total estra-
diol (E2) levels but also on the percentage of
free E2 (2,3). The level of sex hormone-
binding globulin (SHBG), which is a major
determinant ofbiologically available E2, has
also been suggested to affect breast cancer
risk (4,5). However, measurements of
serum levels ofE2 or SHBG have produced
inconsistent results. Epidemiological evi-
dence for their etiological roles is limited
because most data are from case-control
studies.
A recent large-scale prospective study
found that levels of total E2, percent free
E2, and percent E2 bound to SHBG were
related to the risk ofdeveloping breast can-
cer amongpostmenopausal women (6).
It is possible that the known breast cancer
risk factors may be mediated by an estrogen
mechanism. The relationships between the
hormone profile and some ofthe risk factors,
such as earlyage at menarche, nulliparity, and
obesity have been investigated among pre-
menopausal and postmenopausal women
(7-11), but results have been inconsistent.
Therefore, we evaluated serum levels of E2
and SHBG in healthy Japanese pre-
menopausal women with respect to aseries of
breast cancer risk factors. We also explored
factors that some epidemiological studies have
suggested are associated with risk for breast
cancer, such as physical activity (12,13), alco-
hol use (14), and birth month (15,16), to
determine whether they affect hormone pro-
files ofpremenopausalJapanesewomen.
Subjects and Methods
Fifty healthy college women from 21 to 42
years old were studied in January, February,
and March of 1994. Informed consent was
obtained from each subject. Subjects were
asked to complete a self-administered ques-
tionnaire including menstrual status, height
and weight, smoking and drinking habits,
physical activity, reproductive history, oral
contraceptive and other hormone use, previ-
ous disease history, and information on
maternal age at menarche and delivery.
Alcohol consumption was estimated from
frequency ofdrinking and usual serving size
for six different types ofliquors during the
past year. Physical activity was assessed from
the average hours per week spent in strenu-
ous (jogging, tennis, bicycling on hills,
swimming, and aerobics) and moderate
(brisk walking, golfing, bowling, bicycling
on level groundc, and gardening) activities at
13-15 years ofage, 16-18 years, and in the
past year. Each activity level was assigned an
intensity score according to a relative meta-
bolic rate method. Thehours at each level of
activity, weighted by these intensity scores,
were summed to score the physical activity
level of individuals. The validity of this
method was tested by Suzuki et al. for estab-
lishing a physical activity level during the
past year. The Spearman correlation coeffi-
cient was 0.69 (Suzuki et al., unpublished
data) for a comparison between energy
expended as measured by calorimeter or the
calorie counter method (17) and as estimated
from questionnaire data.
No subject had a history of diabetes or
endocrine diseases and none had ever taken
oral contraceptives. There were no current
users of other types of hormonal medica-
tion. One women had used hormonal med-
ication about 2 years before the study, but
onlyfor a few months.
Two blood samples were drawn from
each subject in the mornings of the 11th
and 22nd days ofher menstrual cycle. Day 1
ofthe menstrual cyclewas defined as the day
of onset of menstrual bleeding. After cen-
trifugation, the serum was separated and
stored at -80°C until assayed. Hormone
assays were carried out in one batch in one
laboratory. Serum levels of total E2 and
SHBG were measured radioimmunological-
ly with kits purchased from Diagnostic
Products Corporation (Los Angeles, CA).
The intra-assay coefficients of variation,
based on control pools, were 9.8% for E2
and 5.3% for SHBG.
Hormone concentration was log-trans-
formed for statistical analysis to reduce
departures from the normal distribution. To
assess the association between the logarithm
ofE2 or SHBG level and the studyvariables,
we calculated the Pearson correlation coeffi-
cients. The variables examined in this way
were height, weight, body mass index [BMI;
weight (kg)/height (mi2)], age at menarche,
age at start ofregular cycle, birth order, and
ages at menarche and delivery for the sub-
ject's mother. Although we restricted the
sampling days according to the menstrual
cycle, higher plasma E2 levels were observed
for women with shorter cycles. Therefore,
adjustments for cycle length and age were
performed by regressing the logarithms of
hormones and study variables separately on
these potential confounders. The correlation
coefficients between the two sets ofresiduals
were then calculated. The relationships
between categorical variables [i.e., length of
the menstrual cycle (<27, 28-29, 30, 31-35
days, and irregular), smoking status, and
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month of birth] and the log of hormone
values were analyzed by the multiple regres-
sion technique. All statistical analyses were
performed using PC-SAS, Ver. 6.04 (SAS
Institute, Cary, NC) (18).
Results
The E2 level on the 11th day of the cycle
was strongly associated with the reported
length ofthe menstrual cycle. The trend of
decreasing E2 level with increasing cycle
length was statistically significant on the
11th day ofthe cycle (Table 1).
BMI was significantly correlated with a
decreasing level ofSHBG on the 11th day of
the cycle (r = -0.33; p = 0.03) (Table 2).
BMI also tended to be related to a decreasing
level ofSHBG on the 22nd day ofthe cycle,
but it did not achieve a statistical significance
(r = -0.26; p = 0.09). Birth in a month
between March and August was significandy
associated with increasing level ofSHBG on
the 11th day (p = 0.01) (Table 3).
The relationship between physical
activity at 13-15 years of age and a
decreasing level of E2 on the 11th day of
the cycle was statistically significant after
additional adjustments for BMI and birth
month (r= -0.35;p = 0.04).
There were no significant associations
between E2 level at days 11 or 22 and the
variables for parity, smoking, alcohol con-
sumption, maternal age at delivery, and
ages at menarche and start ofregular cycle.
Discussion
We found that higher physical activity at
13-15 years ofage was related to decreased
E2 levels on the 11th day of the cycle in
adulthood. The previous studies of E2 level
and physical activity have yielded conflicting
results. Decreased levels of E2 in athletic
women have been reported (19,20), but one
study shows no change in E2 level after 1
year of moderate aerobic training (21).
Physical activity at 11-13 years of age may
lower the E2 level later in life, as its intensity
level is relatively high at 13-15 years ofage
(estimated mean weekly energy expenditures
were 3525, 2437, and 729 kcal/week for
13-15 years old, 16-18 years old, and the
past year, respectively). The lack of associa-
tion of E2 levels with physical activity at
16-18 years ofage and the past year may be
due to a relatively low level of activity at
these periods. We cannot deny a possibility
that physical activity may have a profound
effect on menstrual activity when a regular
menstrual cycle should be established.
Physical activity has been reported to be
associated with a lower risk ofbreast cancer
by some investigators (12,13,22). These
authors have suggested that physical activity
should reduce the risk of breast cancer by
Table 1. Geometric mean concentrations (95% confidence intervals) of serum estradiol (E2) and sex hor-
mone-binding globulin (SHBG) by age and cycle length
Number of Follicular phasea Luteal phaseb
Variables subjects E2 (pg/ml) SHBG (nmol/l) E2(pg/ml) SHBG (nmol/l)
Age
<29 26 58.1 (48.2-69.9) 67.9 (57.8-79.7) 90.4(73.2-111.7) 76.4(65.4-89.2)
30-34 14 54.8(43.8-68.7) 78.6 (63.3-97.6) 85.1 (66.1-109.7) 85.1 (71.6-101.2)
.35 10 89.6(56.5-141.8) 74.5(54.1-102.6) 68.7 (44.6-105.9) 79.8(58.2-109.5)
PC=006;p2d 0.03 p1 =0.58;p2= 0.57 p1 =0.43;p2=0.20 p1 =0.73;p2=0.78
Cycle length (days)
25 3 145.1 (85.8-245.5) 90.2(55.5-146.7) 63.9 (33.9-120.6) 98.7 (63.3-153.8)
26 1 65.0 (26.1-161.6) 72.9 (31.4-169.2) 74.1 (24.7-222.6) 80.5(37.3-173.6)
27 1 88.8 (35.7-220.7) 75.2(32.4-174.5) 59.5 (19.8-178.7) 72.3(33.5-155.9)
28 12 91.0(69.9-118.3) 86.0(67.5-109.7) 95.6(69.6-131.3) 97.7 (78.3-122.0)
29 2 66.1 (34.7-125.8) 56.9(31.4-103.2) 129.8(59.6-282.4) 65.2(37.9-112.3)
30 16 48.1 (38.3-60.4) 61.2(49.6-75.6) 66.4(50.5-87.5) 66.8 (55.1-80.9)
34 2 64.9(34.1-123.5) 44.9(24.8-81.4) 76.7 (35.2-166.9) 55.6 (32.3-95.7)
35 2 49.2(25.8-93.6) 87.1 (48.0-157.9) 134.3(61.7-292.3) 102.7(59.7-176.9)
Irregulare 11 47.2(35.9-62.1) 77.4(60.0-99.7) 100.4(72.1-139.9) 81.8(64.9-103.1)
P1 <0.01; P2<0.01 P1 =0.38; P2 = 0.14 P1 =0.42;p2 = 0.59 p1 =0.26;p2 = 0.19
a'The 11th day ofthe menstrual cycle.
1The 22nd day ofthe menstrual cycle.
CFor Fvalues.
dFortrend.
eNot included in calculation fortrend.
Table 2. Correlation coefficientsa of serum estradiol (E2) and sex hormone-binding globulin (SHBG) with
demographic characteristics, reproductive factors, and physical activity
Follicular phaseb Luteal phasec
Variables E2d(pg/ml) SHBGd(nmol/l) E2(pg/ml) SHBG (nmol/l)
Height(cm) 0.06 0.07 -0.14 0.13
Weight (kg) -0.12 -0.24 -0.16 -0.15
Body mass index -0.19 -0.33* -0.11 -0.26
Age at menarche
(years) -0.04 -0.03 0.05 0.00
Age atstart of regular cycle
(years) -0.10 -0.03 0.06 -0.04
Number of births 0.06 -0.10 -0.06 0.00
Birth order 0.17 0.15 -0.20 0.13
Maternal age at
menarche (years) -0.00 -0.07 -0.18 -0.26
Maternal age atbirth
(years) -0.10 0.00 -0.27 -0.02
Physical activity scoree
13-15 years old -0.35* 0.00 0.13 0.09
16-18years old 0.05 -0.12 0.16 -0.06
Inthe pastyear 0.13 -0.07 0.07 -0.03
aAdjusted for age and cycle length.
the 11th day ofthe menstrual cycle.
cThe 22nd day ofthe menstrual cycle.
dTransformed into logarithm.
eAdjusted for age, cycle length, body mass index, a
*p<0.05.
reducing the number of ovulations that
occur during the women's lifetime.
Strenuous activity is associated with
reduced frequency of ovulation or reduced
length of luteal phase (23,24). The length
of the menstrual cycle in the present study
was not significantly associated with physi-
cal activity (r = 0.06, 0.15, and 0.01 for
13-15 years, 16-18 years, and the pastyear,
respectively, after controlling for age and
BMI). The finding of lower E2 levels with
higher physical activity at 13-15 years of
ind birth month.
age is consistent with physical activity
reducing the risk ofbreast cancer.
The inverse association of BMI with
SHBG level in premenopausal women has
been reported by Apter et al. (7) and
Ingram et al. (9). We confirmed these
results in the present study.
Several studies have suggested that expo-
sure to pregnancy estrogens have an impor-
tant role in the etiology of breast cancer
(25-24. Some factors related to pregnancy
estrogen levels, such as maternal age at deliv-
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Table 3. Geometric mean concentrations(95% confidence interval) of serum estradiol (E2) and sex hormone-
binding globulin (SHBG) bysmoking, alcohol consumption, and month of birth
Number of Follicularphaseb Luteal phase
Variables subjects E2 (pg/mi) SHBG (nmol/l) E2 (pg/ml) SHBG (nmol/l)
Smoking
Never 45 64.8 72.4 83.1 79.7
(54.9-76.5) (61.8-84.9) (67.9-101.8) (68.9-92.3)
Ever 5 86.2 81.5 79.2 91.0
(56.6-131.3) (54.5-122.1) (47.3-132.4) (62.7-132.0)
pid = 0.22 P1 = 0.59 P1 = 0.86 P1 = 0.51
Alcohol
consumption
(g/week)
0 14 73.5 70.9 78.4 77.0
(56.6-95.5) (55.3-90.8) (57.2-107.3) (61.1-97.1)
<18.7 18 71.7 67.3 73.6 78.7
(55.8-92.0) (53.1-85.2) (54.6-99.3) (63.1-98.1)
>18.8 18 59.8 81.5 94.6 86.5
(47.5-75.3) (65.4-101.4) (71.7-124.8) (70.5-106.1)
P1 =0.40; p2e= 0.23 P1 =0.44; P2 = 0.39 p1 =0.41;p2 = 0.36 p1 =0.70;p2 = 0.45
Month of birth
September
to February 21 68.6 63.8 72.7 73.1
(56.2-83.6) (53.9-75.5) (57.9-91.4) (62.2-86.1)
March
to August 28 65.1 88.2 100.3 92.5
(51.3-82.5) (72.0-108.0) (76.3-131.8) (76.1-112.3)
P1 = 0.73 P1 = 0.01 P1 = 0.07 P1 = 0.06
aAdjusted for age and length ofmenstrual cycle.
bOn the 11th day ofthe menstrual cycle.
cOn the 22nd day ofthe menstrual cycle.
dFor Fvalues.
eFortrend.
ery and first versus subsequent pregnancies
(28,29), were also related to future breast
cancer risk (30,31). In our data, birth order
as well as maternal age at delivery were not
significantly associated with levels ofE2 and
SHBG. There is no obvious explanation for
the observed association between birth
month and SHBG levels. It may be the
influence ofprenatal or perinatal factors on
SHBG metabolism (conceivably pregnancy
estrogens or other pregnancy hormones may
have seasonal variation), the result of
unknown confounders, or due to chance.
Although we used the BMI as an index
of obesity, there may be a residual con-
founding effect ofobesity for the observed
association between month of birth and
SHBG level.
Among the well-known breast cancer
risk factors, early age at menarche was asso-
ciated with E2 level in the study reported
by Apter et al. (2). However, Ingram et al.
(9) and Bernstein et al. (10) found no evi-
dence of the effect of age at menarche on
the estrogen levels, which was consistent
with the result in the present study.
Positive association between alcohol use
and breast cancer has been observed in
many epidemiological studies (32).
Although alcohol consumption was not
related to E2 level in the present study, the
average and variance of alcohol consump-
tion in the subjects were too small to detect
a significant association. All suitable
women in a college class participated in the
present study, but their alcohol consump-
tion [mean ± standard deviation (SD) of
26.6 ± 39.9 g/week] appeared to be rela-
tively low as compared with other groups
of college women. Our recent survey
(1996) showed that the mean ± SD ofalco-
hol consumption was 47.6 ± 99.4 g/week
in 205 women at two other colleges.
It is difficult to compare the levels ofE2
among premenopausal women because the
E2 level fluctuates greatly during the men-
strual cycle. We restricted the days ofdraw-
ing blood samples during the menstrual
cycle and took the cycle length into consid-
eration because the E2 level on the 11th
day of the cycle was negatively related to
the cycle length. As we could not obtain
the exact date of the onset of subsequent
menstruation from each woman, the
reported cycle length was utilized for con-
trolling its effect after being categorized.
The present study may be still biased
due to the residual confounding effects of
the cycle length. The cycle length has been
indicated to be related to breast cancer risk
(33). It would be better to obtain a large
number ofdata and restrict the analyses to
the subjects with the same cycle lengths.
However, even ifwe have knowledge ofthe
exact cycle lengths of the subjects and the
exact day of the cycle that measurements
are taken and we perform subanalyses
according to cycle length, it is almost
impossible to completely avoid the effects
of confounding factors related to differ-
ences in cycle characteristics on E2 levels
among individuals without repeating the
measurements through the menstrual cycle.
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